CHINA MEDICAL TECHNOLOGIES, INC SPN ADR
CMED
CMED was delisted on the 6th of February, 2012.
1 hedge funds and large institutions have $256 invested in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more capital invested
Capital invested by funds: $256 → $256 ($0)
Top Buyers
Top Sellers
CMED Hedge Fund Activity: Q4 2022 in Review
1 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) for Q4 2022, worth a combined $256 — unchanged from a quarter earlier.
Fund positioning in CMED was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $256 of CHINA MEDICAL TECHNOLOGIES, INC SPN ADR stock for Q4 2022, unchanged quarter-over-quarter.
- 0 funds opened new CHINA MEDICAL TECHNOLOGIES, INC SPN ADR positions in Q4 2022 and 0 closed out.
Based on aggregated 13F filings for Q4 2022.